We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s healthcare costs regulator is recommending Terumo BCT’s Spectra Optia Apheresis System for blood transfusion in managing sickle cell disease, saying the device may lead to fewer treatments that last for shorter periods of time. Read More